Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
×
Thoracic
×
Clear all
Filters
2
NCT02296125
2026-01-09
FLAURA
AstraZeneca
Phase 3
Completed
674 enrolled
21 charts
1 FDA